spacer
home > epc > Spring 2019
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2019

   
Text
PDF
bullet
Supply and Logistics
Reducing Drug Shortages within the Healthcare Industry

Smarter Supply Chains

Yusen LogisticsEllena Austin and James Colson seek to enhance the supply chain by combatting the many challenges which impede the market process, including limited supply, legislation, and logistical burdens.
 
view
download pdf
Overcoming Ongoing Industry Challenges in Clinical Trials
 
Future-Proofing the Supply Chain

From patient recruitment to new regulations, addressing the evolution of the clinical research industry may require taking an on-demand approach to restructure the clinical trial distribution network, argues PRISYM ID’s Simon Jones.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Signant Health Unveils its full Conference Line-up for SCOPE 2020

PHILADELPHIA, PA – February 11, 2020: The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient centricity throughout the coming year and beyond. Subject matter experts from Signant Health will host and participate in key discussions on the importance of eConsent and patient engagement, the impact of data analytics on endpoint quality, and how to integrate sensors and wearables into eCOA trials as part of the patient journey through clinical research.
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement